STOPBAC BID Dry Syrup

Indications:

✔️ Acute Otitis Media
✔️ Acute Bacterial Sinusitis
✔️ Community-Acquired Pneumonia
✔️ Upper Respiratory Tract Infections resistant to Amoxycillin monotherapy

Category: Oral Care Medicines

Description
Reviews (0)

Description

Amoxycillin Trihydrate 400 mg + Potassium Clavulanate 57 mg

High-Strength Protection Against Resistant Paediatric Infections
STOPBAC BID is a high-dose Amoxycillin-Clavulanate formulation specially developed for children requiring enhanced antibacterial coverage. It is recommended when standard amoxycillin therapy is inadequate or when resistance is suspected, delivering effective bacterial eradication with improved patient compliance through convenient twice-daily dosing.

Indications
✔️ Acute Otitis Media
✔️ Acute Bacterial Sinusitis
✔️ Community-Acquired Pneumonia
✔️ Upper Respiratory Tract Infections resistant to Amoxycillin monotherapy

STOPBAC BID — The trusted high-strength choice for faster recovery in children.

Reviews

There are no reviews yet.

Be the first to review “STOPBAC BID Dry Syrup”

Revesta Health Care Limited (RHCL) is committed to delivering life-saving medical solutions—right when they’re needed.

Based in Kolkata, RHCL specializes in critical care injectables and is driven by a passion to transform patient lives through innovation, swift action, and uncompromised quality. Because better healthcare builds a better world.